Octanate (Human Coagulation Factor Viii)

Human Coagulation Factor VIII, the active ingredient in Octanate, is a coagulation factor presented as a sterile solution for intravenous use. It replaces deficient clotting factor in patients with hemophilia A, helping to control and prevent bleeding episodes. GNH USA supplies Octanate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Octanate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Octanate is a recombinant factor VIII product that acts within the intrinsic pathway of the coagulation cascade to manage bleeding disorders.

- Hemophilia A (severe): Provides factor VIII replacement to achieve hemostasis and reduce bleeding frequency. - Hemophilia A (moderate): Supports clot formation to control bleeding episodes. - Hemophilia A (mild) with surgery: Supplies peri‑operative factor VIII to maintain adequate clotting during surgical procedures.

Octanate may exhibit      …  …  …  ...  …  … … … … … … … … … …

Common   g  …  …  ...: -  …  …  ...  ...  ...  ...  ...  …  - place  …  ...  …  ...  ...

****       …  …  ...  … …  …  …  g  … …       …  ewline   ewline     \\